Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, drugstore and pharmacy benefits giant CVS Caremark (CVS +0.10%) has earned a coveted five-star ranking.
With that in mind, let's take a closer look at CVS Caremark and see what CAPS investors are saying about the stock right now.
CVS Caremark facts
|
| |
|---|---|
|
Headquarters (founded) |
Woonsocket, R.I. (1892) |
|
Market Cap |
$63.9 billion |
|
Industry |
Drug retail |
|
Trailing-12-Month Revenue |
$123.1 billion |
|
Management |
CEO Larry Merlo (since 2011) CFO David Denton (since 2010) |
|
Return on Equity (average, past 3 years) |
9.6% |
|
Cash/Debt |
$1.4 billion/$9.8 billion |
|
Dividend Yield |
1.7% |
|
Competitors |
Express Scripts Holding (ESRX +0.00%) Walgreen (WAG +0.00%) Wal-Mart Stores (WMT +1.44%) |
Sources: S&P Capital IQ and Motley Fool CAPS.
On CAPS, 96% of the 1,769 members who have rated CVS Caremark believe the stock will outperform the S&P 500 going forward.
Just last week, one of those Fools, ValueInvestor747, tapped CVS Caremark as a particularly solid income opportunity:
Not my traditional investment as I'm relying on more growth than anything, but still pays a decent dividend and valuation is OK. They have impressed me with [year-over-year] revenue growth and with the baby boomers continuing to age, I see huge growth. It may take a few years, but I have time.
Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.
